Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
Recent Posts
One year and five companies later, the Translational Sciences team is making a big impact at UPMC Enterprises
Less than 18 months later, that Enterprises team is nearly 20 strong and already seeing …
Read More →
Life Sciences Week Recap: The future of health care is here in Pittsburgh
Pittsburgh Life Sciences Week took place May 13 – May 17 and featured local and …
Read More →